Equivalence of Earlobe Site Blood Glucose Testing With Finger Stick

2008 ◽  
Vol 17 (4) ◽  
pp. 251-261 ◽  
Author(s):  
Patricia Anzalone
2018 ◽  
Vol 44 (2) ◽  
pp. 188-200
Author(s):  
Ann R. Kaisen ◽  
Janet A. Parkosewich ◽  
Kelly A. Bonito

Purpose The purpose of the study was to identify the rate and factors associated with timely mealtime capillary blood glucose (CBG) testing and insulin coverage in hospitalized patients with diabetes. Methods A descriptive-correlational design was used with a random sample of patients (n = 77) and nurses (n = 36) on a medicine and a neuroscience unit of a large Magnet hospital. After written consent was obtained, post-meal patient and nurse interviews were conducted to collect information about patient, nurse, and situational factors known to influence timely mealtime diabetes care. Results Timely CBG testing occurred on 85.7% of the patient participants, and 71.4% received timely insulin coverage. Timely CBG testing was associated (unadjusted) with telling the patient care associate to obtain a finger stick (FS) prior to meals and patient off the unit during mealtime. The odds of having insulin administered on time was significantly and independently associated with the nurse caring for fewer patients, patients waiting for insulin prior to eating, and patients knowing pre-meal FS was high. Conclusions One situational factor and 2 patient factors were independently associated with timely insulin coverage prior to meals. Interventions aimed at raising staff awareness of these factors and providing tailored education to patients may improve the odds of having insulin administered on time.


2000 ◽  
Vol 2 (2) ◽  
pp. 221-229 ◽  
Author(s):  
Ben Feldman ◽  
Geoff McGarraugh ◽  
Adam Heller ◽  
Nancy Bohannon ◽  
Jay Skyler ◽  
...  

2003 ◽  
Vol 5 (6) ◽  
pp. 983-989 ◽  
Author(s):  
D. Fedele ◽  
A. Corsi ◽  
C. Noacco ◽  
F. Prisco ◽  
S. Squatrito ◽  
...  

2021 ◽  
pp. 1-9
Author(s):  
Haifen Zhang ◽  
Shuhui Lailan ◽  
Shiyu Zhao ◽  
Qian Liu ◽  
Nina Fang ◽  
...  

BACKGROUND: Portable blood glucose meters are the main method for detecting the blood glucose status of clinical patients. OBJECTIVE: To investigate the accuracy of detecting blood glucose in haemodialysis patients by sampling two blood glucose meters through the haemodialysis line. METHODS: Convenient sampling was used to select 80 patients with maintenance haemodialysis. The patients were sampled through the arterial end of the haemodialysis line within three minutes of being put on the machine. One specimen was tested by glycemeter1, which can identify the type of blood in the arteries and veins, and glycemeter2, which can only detect blood glucose in the capillaries for bedside blood glucose testing. The other specimen was sent to the laboratory biochemical analyser for blood glucose testing. RESULTS: When the blood glucose value of the first blood glucose meter (No. 1) was compared with the laboratory biochemical analyser, the correlation coefficient was r = 0.805 (p < 0.05), the out of value of the first blood glucose meter accounted for 4.4%, and the consistency reached 95% (p < 0.05). When the blood glucose value of the second blood glucose meter (No. 2) was compared with the laboratory biochemical analyser, the correlation coefficient was r = 0.800 (p < 0.05), the out of value of the second blood glucose meter accounted for 4.4%, and the consistency reached 95% (p < 0.05). CONCLUSIONS: For patients with maintenance haemodialysis, the blood glucose values detected by the two bedside blood glucose meters using arteriovenous mixed blood in the pipeline do not affect the accuracy and can respond more realistically.


2016 ◽  
Vol 33 (9) ◽  
pp. 313-315a ◽  
Author(s):  
Steve Chaplin

Diabetes Care ◽  
1981 ◽  
Vol 4 (3) ◽  
pp. 417-419 ◽  
Author(s):  
P. Kubilis ◽  
A. L. Rosenbloom ◽  
D. Lezotte ◽  
J. H. Silverstein ◽  
P. Cimino ◽  
...  

Author(s):  
Ali Abdallah ◽  
Brandon Heid ◽  
Hajra Khan ◽  
Nigil Valikodath

We were approached by an amputee diabetic to build a device that could test blood sugar with the use of only one arm. Originally, this product was client based only. It was designed for an elderly diabetic amputee such that the device would allow him to single-handedly manage his blood glucose testing without any extra assistance from other persons. Although this was originally a client-specific device, it is expected to have a broader market based on the prevalence of arm amputations among the diabetic patient population. Statistics reveal that over 80,000 amputations are performed each year in the United States on people with diabetes. [1] The target audience is also intended for older individuals who suffer from having limited fine motor coordination due to conditions such as arthritis. Diabetic patients must test their glucose level several times a day, and therefore it is absolutely critical to have a glucose-testing device that allows a user to test his or her glucose-level with no trouble. This device would provide these diabetic patients with access to a more convenient and user-friendly system that would allow an individual to test his or her blood glucose level with ease.


2007 ◽  
Vol 13 (4) ◽  
pp. 65-82 ◽  
Author(s):  
Joanne Gallivan ◽  
Mimi Lising ◽  
Neyal J. Ammary ◽  
Rachel Greenberg

The National Diabetes Education Program (NDEP) is a federally sponsored national partnership including government, nonprofit, professional, and private sector organizations. The NDEP uses social marketing principles and processes to develop and implement awareness campaigns and educational activities to improve the treatment and health status of people with diabetes. Co-sponsored by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), NDEP launched its “Control Your Diabetes. For Life.” awareness campaign in 1998. The campaign was designed to educate the millions of Americans with diabetes and their social supporters about the seriousness of diabetes, ways to control the disease, and the benefits of good glucose control. The NDEP conducted extensive audience research and applied behavior change theories and the social marketing framework to design, implement, and evaluate the campaign. From 1998 to 2003, the campaign achieved at least 700 million media impressions with its culturally appropriate television and radio public service announcements, print ads, and newspaper and magazine stories. In addition, over half of people with diabetes indicated awareness of the campaign and NDEP has tracked positive trends in practice of blood glucose testing and awareness of the A1C (also known as the hemoglobin A1C), the best measure of blood glucose control, since the campaign's launch.


Sign in / Sign up

Export Citation Format

Share Document